Literature DB >> 8944564

Intestinal transit in anxiety and depression.

D A Gorard1, J E Gomborone, G W Libby, M J Farthing.   

Abstract

BACKGROUND: Patients with anxiety and depression often have bowel symptoms. Until now, studies investigating a link between altered bowel habit and psychological illness have focused on patients with disturbed defecation presenting to gastroenterologists. AIMS: To determine whether patients with anxiety and depression have objective evidence of abnormal intestinal transit irrespective of any bowel symptoms.
METHODS: 21 psychiatric outpatients fulfilling research criteria for generalised anxiety disorder and/or major depression, and 21 healthy volunteers were studied. Orocaecal transit time (OCTT) was measured by lactulose hydrogen breath test. Whole gut transit time (WGTT) was measured by abdominal radiography after ingestion of radio-opaque markers.
RESULTS: Median (range) WGTT was shorter in patients with anxiety (14 (6-29) hours) than in patients with depression (49 (35-71) hours) (p < 0.001), and controls (42 (10-68) hours) (p < 0.001). In patients with anxiety, orocaecal transit time was shorter (60 (10-70) minutes) than in patients with depression (110 (60-180) minutes) (p < 0.01), and shorter than in controls (75 (50-140)) minutes (p < 0.05). The prolongation of transit times in depression compared with controls was not significant. However, WGTT correlated with both the Beck Depression Inventory score (r = 0.59, p < 0.01) and the depression score of the Hospital Anxiety and Depression scale (r = 0.66, p < 0.001).
CONCLUSIONS: These objective measurements of intestinal transit in affective disorders are consistent with clinical impressions that anxiety is associated with increased bowel frequency, and depressed patients tend to be constipated; mood has an effect on intestinal motor function.

Entities:  

Mesh:

Year:  1996        PMID: 8944564      PMCID: PMC1383268          DOI: 10.1136/gut.39.4.551

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  40 in total

1.  An inventory for measuring depression.

Authors:  A T BECK; C H WARD; M MENDELSON; J MOCK; J ERBAUGH
Journal:  Arch Gen Psychiatry       Date:  1961-06

2.  Experimental studies on the irritable colon.

Authors:  T P ALMY
Journal:  Am J Med       Date:  1951-01       Impact factor: 4.965

3.  Colonic transit scintigraphy. A physiologic approach to the quantitative measurement of colonic transit in humans.

Authors:  B Krevsky; L S Malmud; F D'Ercole; A H Maurer; R S Fisher
Journal:  Gastroenterology       Date:  1986-11       Impact factor: 22.682

4.  Levels of anxiety in colonic disorders.

Authors:  M D Esler; K J Goulston
Journal:  N Engl J Med       Date:  1973-01-04       Impact factor: 91.245

Review 5.  Defecation and the pathophysiology of constipation.

Authors:  N W Read; J M Timms
Journal:  Clin Gastroenterol       Date:  1986-10

6.  Increased colonic motility during exposure to a stressful situation.

Authors:  F Narducci; W J Snape; W M Battle; R L London; S Cohen
Journal:  Dig Dis Sci       Date:  1985-01       Impact factor: 3.199

7.  Dietary fiber and personality factors as determinants of stool output.

Authors:  D M Tucker; H H Sandstead; G M Logan; L M Klevay; J Mahalko; L K Johnson; L Inman; G E Inglett
Journal:  Gastroenterology       Date:  1981-11       Impact factor: 22.682

8.  Psychological stress and the passage of a standard meal through the stomach and small intestine in man.

Authors:  P A Cann; N W Read; J Cammack; H Childs; S Holden; R Kashman; J Longmore; S Nix; N Simms; K Swallow; J Weller
Journal:  Gut       Date:  1983-03       Impact factor: 23.059

9.  Towards positive diagnosis of the irritable bowel.

Authors:  A P Manning; W G Thompson; K W Heaton; A F Morris
Journal:  Br Med J       Date:  1978-09-02

10.  The hospital anxiety and depression scale.

Authors:  A S Zigmond; R P Snaith
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

View more
  25 in total

1.  British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome.

Authors:  J Jones; J Boorman; P Cann; A Forbes; J Gomborone; K Heaton; P Hungin; D Kumar; G Libby; R Spiller; N Read; D Silk; P Whorwell
Journal:  Gut       Date:  2000-11       Impact factor: 23.059

2.  Meta-analysis of oro-cecal transit time in fasting subjects.

Authors:  Tohru Kokubo; Shigeyuki Matsui; Makio Ishiguro
Journal:  Pharm Res       Date:  2012-09-28       Impact factor: 4.200

3.  Intestinal reactivity to words with emotional content and brain information processing in irritable bowel syndrome.

Authors:  S Blomhoff; S Spetalen; M B Jacobsen; M Vatn; U F Malt
Journal:  Dig Dis Sci       Date:  2000-06       Impact factor: 3.199

4.  Treatment of functional diarrhea.

Authors:  Evan S Dellon; Yehuda Ringel
Journal:  Curr Treat Options Gastroenterol       Date:  2006-07

5.  Use of a device that applies external kneading-like force on the abdomen for treatment of constipation.

Authors:  Konstantinos Mimidis; David Galinsky; Efraim Rimon; Vassilios Papadopoulos; Yehuda Zicherman; Dimitrios Oreopoulos
Journal:  World J Gastroenterol       Date:  2005-04-07       Impact factor: 5.742

6.  The signaling of amitriptyline-induced inhibitory effect on electrical field stimulation response in colon smooth muscle.

Authors:  Tin Sandar Zaw; Phyu Phyu Khin; Uy Dong Sohn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-05-28       Impact factor: 3.000

Review 7.  Finding intestinal fortitude: Integrating the microbiome into a holistic view of depression mechanisms, treatment, and resilience.

Authors:  M C Flux; Christopher A Lowry
Journal:  Neurobiol Dis       Date:  2019-08-24       Impact factor: 5.996

8.  Can breast ultrasound reduce patient's level of anxiety and pain?

Authors:  Fariba Zarei; Parisa Pishdad; Mohammad Hatami; Banafsheh Zeinali-Rafsanjani
Journal:  Ultrasound       Date:  2017-02-16

9.  Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome.

Authors:  Y Sagami; Y Shimada; J Tayama; T Nomura; M Satake; Y Endo; T Shoji; K Karahashi; M Hongo; S Fukudo
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

10.  Pan-enteric dysmotility, impaired quality of life and alexithymia in a large group of patients meeting ROME II criteria for irritable bowel syndrome.

Authors:  Piero Portincasa; Antonio Moschetta; Giuseppe Baldassarre; Donato F Altomare; Giuseppe Palasciano
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.